Apical membrane antigen 1 as an anti-malarial drug target

Current Topics in Medicinal Chemistry

Volumn 11, Issue 16, 2011, Pages 2039-2047

  Macraild, Christopher A ^a,b   Anders, Robin F ^c   Foley, Michael ^c   Norton, Raymond S ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

Antibodies; Malaria; Merozoite; Peptides; Three dimensional structure

Indexed keywords

ANTIMALARIAL AGENT; APICAL MEMBRANE ANTIGEN 1; MALARIA VACCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1F9; PEPTIDE DERIVATIVE; SHARK ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIMALARIAL ACTIVITY; ARTICLE; BINDING AFFINITY; CELL INVASION; COMPLEX FORMATION; DRUG DESIGN; DRUG SPECIFICITY; DRUG TARGETING; GAP JUNCTION; HOST CELL; MALARIA; MEROZOITE; NONHUMAN; PHAGE DISPLAY; PLASMODIUM; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

ANTIBODIES; ANTIGENS, PROTOZOAN; ANTIMALARIALS; BINDING SITES; CELL MEMBRANE; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; ERYTHROCYTES; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MALARIA, VIVAX; MEMBRANE PROTEINS; MEROZOITES; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS;

EID: 80051699901     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802611796575885     Document Type: Article

References (68)

1. WHO World Malaria Report; 2009.
2. Breman, J.G.; Alilio, M.S.; Mills, A. Conquering the intolerable burden of malaria: what's new, whats needed: a summary. Am. J. Trop. Med. Hyg., 2004, 71, 1-15.
3. Anders, R.F.; Adda, C.G.; Foley, M.; Norton, R.S. Recombinant protein vaccines against the asexual blood-stages of Plasmodium falciparum. Hum. Vaccin, 2010, 6(1), 39-53.
4. Wells, T.N.C.; Alonso, P.L.; Gutteridge, W.E. New medicines to improve control and contribute to the eradication of malaria. Nat. Rev. Drug Discov., 2009, 8, 879-891.
5. Enserink, M. Malaria's drug miracle in danger Science, 2010, 328, 844-846.
6. Fidock, D.A.; Eastman, R.T.; Ward, S.A.; Meshnick, S.R. Recent highlights in antimalarial drug resistance and chemotherapy. Trends Parasitol., 2008, 24, 537-544.
7. Anstey, N.M.; Russell, B.; Yeo, T.W.; Price, R.N. The pathophysiology of vivax malaria. Trends Parasitol., 2009, 25(5), 220-227.
8. Miller, L.H.; Baruch, D.I.; Marsh, K.; Doumbo, O.K. The pathogenic basis of malaria. Nature, 2002, 415, 673-679.
9. Baum, J.; Papenfuss, A.T.; Baum, B.; Speed, T.P.; Cowman, A.F. Regulation of apicomplexan actin-based motility. Nat. Rev. Microbiol., 2006, 4, 621-628.
10. Cowman, A.F.; Crabb, B.S. Invasion of red blood cells by malaria parasites. Cell, 2006, 124, 755-766.
11. Kappe, S.H.I.; Vaughan, A. M.; Boddey, J.A.; Cowman, A.F. That was then but this is now: malaria research in the time of an eradication agenda. Science, 2010, 328, 862-866.
12. Triglia, T.; Healer, J.; Caruana, S.R.; Hodder, A.N.; Anders, R.F.; Crabb, B.S.; Cowman, A.F. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol. Microbiol., 2000, 38, 706-718.
13. Silvie, O.; Franetich, J.F.; Charrin, S.; Mueller, M.S.; Siau, A.; Bodescot, M.; Rubinstein, E.; Hannoun, L.; Charoenvit, Y.; Kocken, C.H.; Thomas, A.W.; Van Gemert, G.J.; Sauerwein, R.W.; Blackman, M.J.; Anders, R.F.; Pluschke, G.; Mazier, D. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem., 2004, 279, 9490-9496.
14. Fowkes, F.J.; Richards, J.S.; Simpson, J.A.; Beeson, J.G. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. PLoS Med., 2010, 7, e1000218.
15. Hodder, A.N.; Crewther, P.E.; Anders, R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun., 2001, 69, 3286-3294.
16. Remarque, E.J.; Faber, B.W.; Kocken, C.H.; Thomas, A.W. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol., 2008, 24, 74-84.
17. Blackman, M.J.; Bannister, L.H. Apical organelles of Apicomplexa: biology and isolation by subcellular fractionation. Mol. Biochem. Parasitol., 2001, 117, 11-25.
18. Healer, J.; Crawford, S.; Ralph, S.; McFadden, G.; Cowman, A.F. Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect. Immun., 2002, 70(10), 5751-5758.
19. Narum, D.L.; Thomas, A.W. Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol., 1994, 67, 59-68.
20. Howell, S.A.; Withers-Martinez, C.; Kocken, C.H.; Thomas, A.W.; Blackman, M.J. Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J. Biol. Chem., 2001, 276, 31311-31320.
21. Bannister, L.H.; Mitchell, G.H.; Butcher, G.A.; Dennis, E.D.; Cohen, S. Structure and development of the surface coat of erythrocytic merozoites of Plasmodium knowlesi. Cell Tissue Res., 1986, 245, 281-290.
22. Langreth, S.G.; Jensen, J.B.; Reese, R.T.; Trager, W. Fine structure of human malaria in vitro. J. Protozool., 1978, 25, 443-452.
23. Aikawa, M.; Miller, L.H.; Johnson, J.; Rabbege, J. Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J. Cell Biol., 1978, 77, 72-82.
24. Baum, J.; Richard, D.; Healer, J.; Rug, M.; Krnajski, Z.; Gilberger, T.W.; Green, J.L.; Holder, A.A.; Cowman, A.F. A conserved molecular motor drives cell invasion and gliding motility across malaria life cycle stages and other apicomplexan parasites. J. Biol. Chem., 2006, 281, 5197-5298.
25. Bannister, L.H.; Mitchell, G.H. The fine structure of secretion by Plasmodium knowlesi merozoites during red cell invasion. J. Protozool., 1989, 36, 362-367.
26. Bannister, L.H.; Mitchell, G.H.; Butcher, G.A.; Dennis, E.D. Lamellar membranes associated with rhoptries in erythrocytic merozoites of Plasmodium knowlesi: a clue to the mechanism of invasion. Parasitology, 1986, 92, 291-303.
27. Lebrun, M.; Michelin, A.; El Hajj, H.; Poncet, J.; Bradley, P.J.; Vial, H.; Dubremetz, J.-F. The rhoptry neck protein RON4 relocalizes at the moving junction during Toxoplasma gondii invasion. Cell Microbiol., 2005, 7, 1823-1833.
28. Alexander, D.L.; Mital, J.; Ward, G.E.; Bradley, P.; Boothroyd, J.C. Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS Pathog., 2005, 1, e17.
29. Alexander, D.L.; Arastu-Kapur, S.; Dubremetz, J.F.; Boothroyd, J.C. Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to TgRON4, a component of the moving junction in Toxoplasma gondii. Eukaryot Cell, 2006, 5, 1169-73.
30. Cao, J.; Kaneko, O.; Thongkukiakul, A.; Tachibana, M.; Otsuki, H.; Gao, Q.; Tsuboi, T.; Torii, M. Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasitol. Int., 2009, 58, 29-35.
31. Collins, C.R.; Withers-martinez, C.; Hackett, F.; Blackman, M.J. An inhibitory antibody blocks interactions between components of the malarial invasion machinery. PLoS Pathog., 2009, 5(1), e1000273
32. Morahan, B.J.; Sallmann, G.B.; Huestis, R.; Dubljevic, V.; Waller, K.L. Plasmodium falciparum: genetic and immunogenic characterisation of the rhoptry neck protein PfRON4. Exp. Parasitol., 2009, 122, 280-288.
33. Richard, D.; MacRaild, C.A.; Riglar, D.T.; Chan, J.; Foley, M.; Baum, J.; Ralph, S.A.; Norton, R.S.; Cowman, A.F. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J. Biol. Chem., 2010, 285, 14815-14822.
34. Narum, D.L.; Nguyen, V.; Zhang, Y.; Glen, J.; Shimp, R.L.; Lambert, L.; Ling, I.T.; Reiter, K.; Ogun, S.A.; Long, C.; Holder, A.A.; Herrera, R. Identification and characterization of the Plasmodium yoelii PyP140/RON4 Protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection. Infect. Immun., 2008, 76, 4876-4882.
35. Proellocks, N.I.; Coppel, R.L.; Waller, K.L. Dissecting the apicomplexan rhoptry neck proteins. Trends Parasitol., 2010, 2-9.
36. Bestiero, S.; Michelin, A.; Poncet, J.; Dubremetz, J.-F.; Lebrun, M. Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion. PLoS Pathog., 2009, 5(2), e1000309
37. Boyle, M.J.; Wilson, D.W.; Richards, J.S.; Riglar, D.T.; Tetteh, K.K.; Conway, D.J.; Ralph, S.A.; Baum, J.; Beeson, J.G. Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc. Natl. Acad. Sci. USA, 2010, 107(32),14378-14383
38. Leykauf, K.; Treeck, M.; Gilson, P.R.; Nebl, T.; Braulke, T.; Cowman, A.F.; Gilberger, T.W.; Crabb, B.S. Protein Kinase A dependent phosphorylation of apical membrane antigen 1 plays an important role in erythrocyte invasion by the malaria parasite. PLoS Pathog., 2010, 6, e1000941.
39. Treeck, M.; Zacherl, S.; Herrmann, S.; Cabrera, A.; Kono, M.; Struck, N.S.; Engelberg, K.; Haase, S.; Frischknecht, F.; Miura, K.; Spielmann, T.; Gilberger, T.W. Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process. PLoS Pathog., 2009, 5, e1000322.
40. Hodder, A.N.; Crewther, P.E.; Matthew, M.L.; Reid, G.E.; Moritz, R.L.; Simpson, R.J.; Anders, R.F. The disulfide bond structure of Plasmodium apical membrane antigen-1. J. Biol. Chem., 1996, 271, 29446-29452.
41. Nair, M.; Hinds, M.G.; Coley, A.M.; Hodder, A.N.; Foley, M.; Anders, R.F.; Norton, R.S. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). J. Mol. Biol., 2002, 322, 741-753.
42. Cortes, A.; Mellombo, M.; Mueller, I.; Benet, A.; Reeder, J.C.; Anders, R.F. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Infect. Immun., 2003, 71, 1416-1426.
43. Escalante, A.A.; Grebert, H.M.; Chaiyaroj, S.C.; Magris, M.; Biswas, S.; Nahlen, B.L.; Lal, A.A. Polymorphism in the gene encoding the apical membrane antigen 1 (AMA1) of Plasmodium falciparum. X. Asembo Bay cohort project. Mol. Biochem. Parasitol., 2001, 113(2), 279-287.
44. Polley, S.D.; Chokejindachai, W.; Conway, D.J. Allele frequency-based analyses robustly map sequence sites under balancing selection in a malaria vaccine candidate antigen. Genetics, 2003, 165, 555-561.
45. Pizarro, J.C.; Vulliez-Le Normand, B.; Chesne-Seck, M.L.; Collins, C.R.; Withers-Martinez, C.; Hackett, F.; Blackman, M.J.; Faber, B.W.; Remarque, E.J.; Kocken, C.H.; Thomas, A.W.; Bentley, G.A. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science, 2005, 308, 408-11.
46. Bai, T.; Becker, M.; Gupta, A.; Strike, P.; Murphy, V.J.; Anders, R.F.; Batchelor, A.H. Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc. Natl. Acad. Sci. USA, 2005, 102, 12736-41.
47. Coley, A.M.; Gupta, A.; Murphy, V.J.; Bai, T.; Kim, H.; Foley, M.; Anders, R.F.; Batchelor, A.H. Structure of the malaria antigen AMA1 in complex with a growth-inhibitory antibody. PLoS Pathog., 2007, 3, 1308-19.
48. Feng, Z.P.; Keizer, D.W.; Stevenson, R.A.; Yao, S.; Babon, J.J.; Murphy, V.J.; Anders, R.F.; Norton, R.S. Structure and inter-domain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1. J. Mol. Biol., 2005, 350, 641-656.
49. 15N resonances of domain III of the ectodomain of apical membrane antigen 1 from Plasmodium falciparum. J. Biomol. NMR, 2001, 19, 85-86.
50. Colman, P.M. Virus versus antibody. Structure, 1997, 5, 591-593.
51. Colman, P.M.; Laver, W.G.; Varghese, J.N.; Baker, A.T.; Tullock, P.A.; Air, G.M.; Webster, R.G. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature, 1987, 326, 358-363.
52. Tulip, W.R.; Varghese, J.N.; Laver, W.G.; Webster, R.G.; Colman, P.M. Refined structure of the influenza virus N9 neuraminidase-NC41 Fab complex. J. Mol. Biol., 1992, 227, 122-148.
53. Kwong, P.D.; Doyle, M.L.; Caspar, D.J.; Cicala, C.; Leavitt, S.A.; Majeed, S.; Steenbeke, T.D.; Venturi, M.; Chaiken, I.; Fung, M.; Katinger, H.; Parren, P.; Robinson, J.; Van Ryk, D.; Wang, L.; Burton, D.R.; Friere, E.; Wyatt, R.; Sodroski, J.; Hendrickson, W.A.; Arthos, J. HIV-1 evades antibody-mediated neutralisation through conformational masking of receptor binding sites. Nature, 2002, 420, 678-682.
54. Coley, A.M.; Campanale, N.V.; Casey, J.L.; Hodder, A.N.; Crewther, P.E.; Anders, R.F.; Tilley, L.M.; Foley, M. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. Protein Eng., 2001, 14, 691-698.
55. Coley, A.M.; Parisi, K.; Masciantonio, R.; Hoeck, J.; Casey, J.L.; Murphy, V.J.; Harris, K.S.; Batchelor, A.H.; Anders, R.F.; Foley, M. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect. Immun., 2006, 74, 2628-2636.
56. Nuttall, S.D.; Humberstone, K.S.; Krishnan, U.V.; Carmichael, J.A.; Doughty, L.; Hattarki, M.; Coley, A.M.; Casey, J.L.; Anders, R.F.; Foley, M.; Irving, R.A.; Hudson, P.J. Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1. Proteins, 2004, 55, 187-197.
57. Henderson, K.A.; Streltsov, V.A.; Coley, A.M.; Dolezal, O.; Hudson, P.J.; Batchelor, A.H.; Gupta, A.; Bai, T.; Murphy, V.J.; Anders, R.F.; Foley, M.; Nuttall, S.D. Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure, 2007, 15, 1452-66.
58. Harris, K.S.; Casey, J.L.; Coley, A.M.; Karas, J.A.; Sabo, J.K.; Tan, Y.; Dolezal, O.; Norton, R.S.; Hughes, A.B.; Scanlon, D.; Foley, M. Rapid optimisation of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning. J. Biol. Chem., 2009, 284, 9361-9371.
59. Harris, K.S.; Casey, J.L.; Coley, A.M.; Masciantonio, R.; Sabo, J.K.; Keizer, D.W.; Lee, E.F.; McMahon, A.; Norton, R.S.; Anders, R.F.; Foley, M. Binding hot spot for invasion inhibitory molecules on Plasmodium falciparum apical membrane antigen 1. Infect. Immun., 2005, 73, 6981-6989.
60. Keizer, D.W.; Miles, L.A.; Li, F.; Nair, M.; Anders, R.F.; Coley, A.M.; Foley, M.; Norton, R.S. Structures of phage-display peptides that bind to the malarial surface protein, apical membrane antigen 1, and block erythrocyte invasion. Biochemistry, 2003, 42, 9915-9923.
61. Li, F.; Dluzewski, A.; Coley, A.M.; Thomas, A.; Tilley, L.; Anders, R.F.; Foley, M. Phage-displayed peptides bind to the malarial protein apical membrane antigen-1 and inhibit the merozoite invasion of host erythrocytes. J. Biol. Chem., 2002, 277, 50303-50310.
62. Collins, C.R.; Withers-Martinez, C.; Bentley, G.A.; Batchelor, A.H.; Thomas, A.W.; Blackman, M.J. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J. Biol. Chem., 2007, 282, 7431-7441.
63. Dutta, S.; Lee, S.Y.; Batchelor, A.H.; Lanar, D.E. Structural basis of antigenic escape of a malaria vaccine candidate. Proc. Natl. Acad. Sci. USA, 2007, 104, 12488-12493.
64. Takala, S.L.; Coulibaly, D.; Thera, M.A.; Batchelor, A.; Cummings, M.P.; Escalante, A.A.; Ouattara, A.; Traore, A.; Niangaly, A.; Djimde, A.A.; Doumbo, O.K.; Plowe, C.V. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci. Trans. Med., 2009, 1, 2ra5.
65. Sanchez, C.P.; Dave, A.; Stein, W.D.; Lanzer, M. Transporters as mediators of drug resistance in Plasmodium falciparum. Int. J. Parasitol., 2010, 40, 1109-1118.
66. Sharma, A. Malarial protease inhibitors: potential new chemo-therapeutic agents. Curr. Opin. Invest. Drug, 2007, 8, 642-652.
67. Theobold, D.L.; Wuttke, D.S. THESEUS: Maximum likelihood superpositioning and analysis of macromolecular structures. Bioinformatics, 2006, 22, 2171-2172.
68. Capra, J.A.; Laskowski, R.A.; Thornton, J.M.S. M; Funkhouser, T.A. Predicting protein ligand binding sites by combining evolutionary sequence conservation and 3D structure. PLoS Comput. Biol., 2009, 5, e1000585.